Exhibit 107

Calculation of Filing Fee Table

Form S-8

(Form Type)

MIRA Pharmaceuticals, Inc.

(Exact Name of Registrant as Specified in its Charter)

Table 1: Newly Registered Securities

Security Type	Security Class Title	Fee Calculation Rule	Amount Registered(1)		Proposed Maximum Offering Price Per Share		Maximum Aggregate Offering Price		Fee Rate		Amount of Registration Fee
Equity	Common Stock, $0.0001 par value per share, reserved for issuance pursuant to options outstanding under the MIRA Pharmaceuticals, Inc. under the 2022 Omnibus Incentive Plan	457(c); 457(h)		5,147,808	$	1.085 (2)	$	5,585,371.68	$	0.0001476	$	824.40
Total Offering Amount				5,147,808			$	5,585,371.68			$	824.40
Total Fees Previously Paid												—
Total Fee Offsets												—
Net Fee Due											$	824.40

(1)	Pursuant to Rule 416(a) under the Securities Act of 1933, as amended (the “Securities Act”), this registration statement (the “Registration Statement”) shall also cover any additional ordinary shares that become issuable under the MIRA Pharmaceuticals, Inc. 2022 Omnibus Incentive Plan (the “Plan”) by reason of any share dividend, share split, recapitalization or other similar transaction.
(2)	The proposed maximum offering price per share is calculated in accordance with Rules 457(c) and 457(h) under the Securities Act, solely for purposes of calculating the registration fee on the basis of $1.085 per share, the average of the high and low price of the Registrant’s Common Stock as reported on the Nasdaq Capital Market on September 25, 2022.